The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Unlocking PARP inhibitor efficacy for HRD-negative cancers using the alphalex tumor targeting platform inhibitor efficacy for HRD-negative cancers using the alphalex tumor targeting platform.
 
Ranjit Bindra
Stock and Other Ownership Interests - Cybrexa Therapeutics
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Ranjini K Sundaram
No Relationships to Disclose
 
Robert J Aiello
No Relationships to Disclose
 
Dan Marshall
No Relationships to Disclose
 
Patricia Bourassa
No Relationships to Disclose
 
Johanna Csengery
No Relationships to Disclose
 
Qing Zhang
No Relationships to Disclose
 
Brett Robinson
No Relationships to Disclose
 
Lori lopresti-Morrow
No Relationships to Disclose
 
Jane Bechtold
No Relationships to Disclose
 
Laurie Tylaska
No Relationships to Disclose
 
Tim Paradis
No Relationships to Disclose
 
Vishwas Paralkar
No Relationships to Disclose
 
Per Hellsund
No Relationships to Disclose
 
Peter Glazer
Stock and Other Ownership Interests - Cybrexa Therapeutics
Consulting or Advisory Role - Cybrexa Therapeutics